Cargando…
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms
Autores principales: | Borsani, Oscar, Ferretti, Virginia V., Casetti, Ilaria C., Vanni, Daniele, Trotti, Chiara, Pietra, Daniela, De Silvestri, Annalisa, Arcaini, Luca, Rumi, Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015773/ https://www.ncbi.nlm.nih.gov/pubmed/36999122 http://dx.doi.org/10.1016/j.rpth.2023.100122 |
Ejemplares similares
-
Risk of Thrombosis in Myeloproliferative Neoplasms after Sars-Cov-2 Vaccination
por: Borsani, Oscar, et al.
Publicado: (2022) -
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms
por: Vanni, Daniele, et al.
Publicado: (2022) -
Autoantibodies Against Type I IFNs in Patients with Ph-Negative Myeloproliferative Neoplasms
por: Borsani, Oscar, et al.
Publicado: (2021) -
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms
por: Borsani, Oscar, et al.
Publicado: (2022) -
P984: MUTATIONAL PATTERNS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS (MPN)
por: Casetti, I. C., et al.
Publicado: (2022)